Golden Developing SOL (DVLP) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 2 sessions, March 6, 2025 to September 23, 2025
Company Description
Golden Developing SOL (OTC: DVLP) is classified in the drug manufacturers - specialty & generic industry within the Healthcare sector.
For FY2022, Golden Developing SOL reported net income of -$1.4M and diluted earnings per share of $0.00.
This page collects what Stock Titan holds for DVLP, including price data, latest news, and financial highlights.
Stock Performance
Golden Developing SOL (DVLP) closed at $0.0001 on September 23, 2025.
Latest News
Golden Developing SOL has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 3 with negative movement. Key topics include acquisition. View all DVLP news →
SEC Filings
Financial Highlights
Golden Developing SOL reported operating income of -$646K in FY2022, and net income was -$1.4M. Diluted earnings per share stood at $0.00. The company generated $183K in operating cash flow. The current ratio was 0.03, measuring current assets divided by current liabilities.
Upcoming Events
DVLP Company Profile & Sector Positioning
Golden Developing SOL (DVLP) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC.
Investors comparing DVLP often look at related companies in the same sector, including Abattis Bioceuticals (ATTBF), Veritas Farms Inc (VFRM), Petlife Pharms Inc (PTLF), Acura Pharms Inc (ACUR), and Clever Leaves Holdings Inc (CLVR). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate DVLP's relative position within its industry.